<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Oakley Health Group</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where The Oakley Health Group is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=060602000&amp;denomIds=6.6.2&amp;selectedTab=summary">Other bisphosphonate and other preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Bisphosphonates and other drugs</td>
      <td>941</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>7.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=060602000BBAAA0&amp;denomIds=6.6.2&amp;selectedTab=summary" target="_blank">Actonel Combi 35mg tab and 1000mg/880unit efferv gran sach : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Intermediate and long-acting insulins</td>
      <td>898</td>
      <td>0.01</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0601012ABBBABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 50microg/ml inj 3ml pf SoloStar pens : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0601012ABAAABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Ins glargine 100u/ml / Lixis 50mcg/ml inj 3ml pf dispos dev : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0208010K0&amp;denomIds=2.8.1&amp;selectedTab=summary">Heparin sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Parenteral anticoagulants</td>
      <td>61</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>5.25</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAANNElEQVR4nO2de9TlUxnHPz8zqVTKahUJsykqabnUjCbXUpJdTENKUYqGTCqEPUSiZrZxnUwGMboYVMp1E6k0zCLT0oVSLtlJhRIRGWL3x7NfHWfOOe+5/M5lznk+a73rfd9zzv49z7l89372s5+9T5FSQlGU0WClfjugKErvUMErygihgleUEUIFrygjhApeUUYIFbyijBAqeEUZIVTwijJCqOAVZYRQwSvKCDE6gi8KrSFWRp6hE7xxYSPjguu3H4oyiAyd4IEdgVnGhRf02xFFGTSGUfCTgX8gwlcUpYJhFPxbgFnAR/rtiKIMGkMleOPCK4EngB8Ak40LL+uzS4oyUAyV4JFwfmn09r/AJcD0PvujKAPFMAr+pvz3IjSsV5TnMIyCX5r//jmwtnHh1X30R1EGiqERvHGhADYGfg0QvU3Ad4AP9tMvRRkkhkbwwCTg/ujtExW3nYeG9YryLMMk+MpwHoDo7W1AYVx4fV88UpQBY6gFn1kEfLjHvijKQDIKgr8A+FCPfVGUgWQoBG9cWAl4PfC76vuit38B7u25Uw0wLkwyLryw334oo8fEfjtQEq8D7swFN7VYBLzduPBJ4CHg4fz7nujt33vkIwDGhdWAJcClwP69tK0oQzHCUz+cH+O8/HsdYBtgL+BLwFLjwm7ddW055gNfA95mXNi6x7aVEacYhu+WMy7MB5ZEb8+v+6CiSKRUVLVbG6m7vwo4Knr7TJf93A2YCbwD2Az4FrBZ9PY/3bSrKGOMyghfk+jtn4GtgXWBi40Lq5bt2BjGhVcBxwF7RW+fjt4uBS4Hvtgtm4pSzQoveOPCysDawF3ttM+j6x7A9cAS48JrS3QPeLYK8Czgy9Hbuyvu+iIwzbjw5rJtKkotBlLwxoUZxoX9mnz4m4BbciltW0RvU/R2LnAYcLVxYfV2r1WHfYBngIVVdh8HPgWcZVx4Xsk2m8K4sLJx4eP9sK30noETvHFhLeQAiz2NC0fn0bERbYXztYjeXgHMBU5vwm5TGBfWAw4HPlmrU4re/hTZ4XdIGfbaYDtgoXFhkz7ZV3rIwAkeEdxs4F2ImE/N6+z1KE3wmTOAFyFhfkdkv78BHBK9va/BQw8F9jYuvK5Tm22wK5K41IM/R4CBErxxYStkTX1hDnenAasB5+a5ei2mUKLg8yj8CeCYHG10wv7AX6O3F45j81/A0cARHdprCePCRGB75Plu2o38hTJYDIzgjQsTgHnAZ6K3TwNEb58C9gQeBC6pzqIbF14EvDR6+9cyfYne3gscBZzdbmhvXFgXOBg4oMkmFwBbltDJtMI2wC9yh3MS/ZtWKD1ikCrt9gFui94uqbwxevuMceEzyLz+FuNCQjLytwPLgJu75M+5yBFZ+wKnt9KwIivvmq3ki94+ZVxYgHQQh7Xoa7vsCnw///1NwBkX1iy7A+0FOel5DLJR6m7k83FH/n1T9PZvfXRvYBiIET6Xm85C5rLLkbPos6O3k4ANgc8BPwLuA07phk85tN8XOMy48JoWm88A/gV8t8V2ZwK7Gxde0mK7lskR1Y5ILQD5HIHTkNd2hcK4sA5wLTL92xhZ+QhAAixwnXHh+X1zcIAYiEo748I85PCK2V0zUqPSrhmMC9OBI5EP0JP5ZxnwGHBJ9Pb+qsevAywG3jpOoq6evZOQGv+udGQVdrYCZkVvd6y4bVXgVmDj6O1D3bTfwK91gGXVr2uDx++MdPqHRW9rdrDGhdOB30RvT2twnTWAs4Fde135mI9heyx6+3AbbYtWlqS7NsI3O/c1LmwE7IDMIQeO6O0PkGTaH4EHgMeBCcBrgBuNC+eMLWnl53wmcGQ7Ys/MA2bmhFo32RV4TjIxevsIUu5b+qYe48IWWcyNHvN2pLNcPF4C0bjw/DxQHAFsV0/smdnA58f5NqLZwGuBgxrZLZv8PgdgQZuX+HwrD+7KCJ/DpxuAs8bpVVcHrgYOj96G0h2ppM0RvhF55WA3JAx+FPglsAHwvk4KgYwL5wMXR2+/U4qjy19/JSQP8pbo7YNV970CWfXYMK+UlGFvdaTW4BngK8DZ1a+PcWFvJHcxHamcnA9Mi97eUuN6GyI5lmuRPMmTTfgwH7g9evvVGvdNQXIu2yHPfWorc/7c0U8Hrore/rvZdrntgcAmSAHZzOjtDS20XQO4MXprmm3TrRHeIR/+jxkXavZAOYz5MXBC18XeJaK3T0Zvz0VqAY4EVgX27UTsmROBg8sq/qnBFOCuarED5CTjZcDeJdqbCxwPvA3YCbhybDXCuDDBuHA8sjS4ZfT21ujtlciOxkuNC5uPXcS4UBgX9kfyDrOitwc1I/bMHOBA48IqlTfmzu9U4HP5uZ+IdEpNkUfo04CTgeU6k3HargV8FlnNOQg4eZyak2pmAye0YrN0wRsXNkCW0g5Eimd2Mi4cVfnhzaHdNcCx0dtvl+1Dr8lJxeujt/vkAzc6vd4vkKnDVp17V5NdqArnqzgBEcfLOzWUcwUbAQvyqLkzcj7B9caFGUjRzxpIWP7AWLvo7XXZz/ONC+/I3yp0KTL92zx6e1UrfuT35RIkoVfJR5GcyU/y/6cDmxsXNmviub0k+zQRiezWNy60ckryKYgG/hG9vRb4G7B7Mw2NC5ORr1VraQWpVMFnUS8ADo3ePpLnhO9BPrg+99DrIhn2w7sVsg4JJyA9f6nk9+j9wMX1HhO9/ROys++iTrLbefQ7Ffh0RW1Fyp38Fsg24RuBj1adNjzmx83ISsIZyPcMXAHs3MGhJR44wLjw4uzfS5ENTM9Gobn24xDgpEYRlnFhTWRKcR0wI/v/EeRzbsZzxLiwI9LRnVNx8yHAl6qjkBptCyTXc1CDQ19qUvYIvweSvb5o7Ibo7WPA+5DltIXInP3g6O1FNa+gjHEFMmKUfeLupkj1X8OkYvT2DGQ+e2YHU4tPI4U9y81Lo7d/id5+KHo7p9EUKHr7e2BbYPvo7YION0ndh0Q2M/NNRwLfyB1cJVciKzHTal3HuPAm4GfAiZX+R2/vQUS7qFHSNQv6ZOBTlWcwRG/vRKKQ8Tr63YEHorfXjPO45ShN8Dn8OwY4oPpNyb3fLkhnMDN6e3lZdoeV/EE4ArjMuLBtiZfehf8X24zHocDLkM0/LZFHwM8i9RUdkTuHOzq9TmYusH8OiXfO/1fbS4jo5lRGOMaFycaFbyJh/N7R2/NqtL0QOVvxqAY+HIEs6S6XkASORfZVrFmrYa4uPZYWs/NjlJalNy6cBfw+ettSEqFndCFL3wvykt+3gB8iy33LOrhWgXwYt49y+EczbV6MjGZzW5mCGRcWAYtzpDBQGBfmIKP8x6O3dTu/XPl4D/BnJFpJyBTlwkbJwizKm5ARfHHVfW9AOoxN62X0jQszgcnR271q3HcMsHL0tq3NTqUI3sjZbPOAKXkONHisoIIHMHLC7RzkdJ49o7e/bbH9+si0aiekqOXdLbZfCxH9Hs0sG+X19OOQ5a2nW7HVC3I0eiDSgdYVQF6ivBlZTZqfk6nN2tgU+B4yhTDINyOthSxN7pdXIuq1nYiscp2BHLY6xsrINGTj6O2jzfpSSceCNy4sRQ6H3Cl6+/OOLtZNVmDBj2FceBeSlV2MlBU/WPHzOPBCYJWK3+sC70WmUpchI8uv2pkH56z1pcAfgPuz/fuz7VdmW+vl3xOB6a0IZBgxLrwTqSmIwJ+Ae5tdRsyvd60vULk8Z/TbI6XU0Q8wo9NrDIodtaE2VlQbzf6UkbSbUcI1BsWO2lAbK6qNphiI3XKKovQGFbyijBBlCP7MEq4xKHbUhtpYUW00xUDsh1cUpTdoSK8oI0RLhywURbE1ssXxgZTSwqIopiMHQdwJ/BbZPPBQSqnt01rGsfFwvu/RlFJLWxGbtZFSuqgoit2BSSkl36XncQOSub0rpbSoXRtN2Pk7clDlaimltkox69iYBuyQUtqv+r4u2ZiG7Bm/PaW0XDlrGTby/bOAu1NKF3TpebwRKef9TUqpL+XlrY7wU7MIXpH/Xz+ldDyyNdACXwY6PTusro2U0k+RHU+dbtusayO/KWUceNjotfoAcuZdGV9e2cjOMqQoptODLJ5jI6V0MVJMUst+6Tby3yciRSxdsVEUxTZArdr20mwgh2Q8UoKNtmlV8NUT/m4kAMazcSjw9S7amIqMJlt00cbzkB1Zb+jQxnh2NkA2anRa7tzofS7rM1D3OkVRTEDe93aPgRrXBvBm5GCQst/3Sl6OnJs3pUMbbdNS0i6HK1OBfyI1xpOQ8PEO4DZk295DKaV5bTvU2MbqyKb/q1NK3+uGjdwjUxSFKyGkr/c8bgU+BjydUjq6XRtN2HkM2BKYkFL6Qok2VkEE6JHz/aYiIew5dS/SmQ2LTD9/nFJq6eCLZm2klJYURWGAt5YQ0td7HiBTrCdSSn05w1Gz9IoyQmiWXlFGCBW8oowQKnhFGSFU8IoyQqjgFWWEUMErygihgleUEUIFrygjhApeUUYIFbyijBAqeEUZIf4HRGoru4uKDXQAAAAASUVORK5CYII="></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0208010K0AAA9A9&amp;denomIds=2.8.1&amp;selectedTab=summary" target="_blank">Heparin sodium 5,000units/1ml inj ampoules : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0604020T0&amp;denomIds=6.4.2&amp;selectedTab=summary">Testosterone undecanoate</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>81</td>
      <td>Male sex hormones and antagonists</td>
      <td>634</td>
      <td>0.13</td>
      <td>0.03</td>
      <td>0.03</td>
      <td>3.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0604020T0AAADAD&amp;denomIds=6.4.2&amp;selectedTab=summary" target="_blank">Testosterone undecanoate 1g/4ml solution for injection vials : 53</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0604020T0BDABAD&amp;denomIds=6.4.2&amp;selectedTab=summary" target="_blank">Nebido 1000mg/4ml solution for injection vials : 28</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0408020Q0&amp;denomIds=4.8.2&amp;selectedTab=summary">Paraldehyde</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Drugs used in status epilepticus</td>
      <td>8</td>
      <td>0.25</td>
      <td>0.01</td>
      <td>0.08</td>
      <td>3.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0408020Q0AAAJAJ&amp;denomIds=4.8.2&amp;selectedTab=summary" target="_blank">Paraldehyde 50% in Olive oil rectal solution : 2</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Oakley Health Group is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0107010Z0&amp;denomIds=1.7.1&amp;selectedTab=summary">Zinc oxide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Soothing haemorrhoidal preparations</td>
      <td>5</td>
      <td>0.20</td>
      <td>0.77</td>
      <td>0.27</td>
      <td>-2.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0107010Z0BCABAF&amp;denomIds=1.7.1&amp;selectedTab=summary" target="_blank">Anusol ointment : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0902012H0&amp;denomIds=9.2.1&amp;selectedTab=summary">Oral rehydration salts</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Oral sodium and water</td>
      <td>22</td>
      <td>0.23</td>
      <td>0.68</td>
      <td>0.31</td>
      <td>-1.47</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0902012H0BBAEAE&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Dioralyte oral powder sachets plain : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0902012H0BBAGAE&amp;denomIds=9.2.1&amp;selectedTab=summary" target="_blank">Dioralyte oral powder sachets blackcurrant : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0301040W0&amp;denomIds=3.1.4&amp;selectedTab=summary">Umeclidinium bromide/vilanterol</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>6</td>
      <td>Compound bronchodilator preparations</td>
      <td>110</td>
      <td>0.05</td>
      <td>0.50</td>
      <td>0.31</td>
      <td>-1.45</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAHJElEQVR4nO3dXYxcZR3H8e/pCytWGiulpRDaYyvlRS1STMyCgjHWCw8BQmLEGzU2KvHC+JLYU01MjKY5jfGFaFKiYsWYaLwQLZzARZPWKtDEALXVC2i1h0VQl7aKBftC278X/2ft7HRadnamc+bs8/skT2Znuj3nv7Pzm+ft7G5iZohIHGbVXYCIDI4CLxIRBV4kIgq8SEQUeJGIKPAiEVHgRSKiwItERIEXiYgCLxKRwQY+SXQdr0iN5tRdgEgv0rx8A7A8tCXA4tAWAW8CLsBf5xPtOHAI+Fe4PQjsB54Gnq6K7MCAv4SBSgb6wzNJYpglgzuhNF2al3OAy4EUWAaswMO9Itw/Cvw1tBeAf4Y2jof5OHCipY0AC/A3gwXAwnC8q4GrgDcC+4DHgUeBx2bSm4ACL32X5uUsYDaTe9aJ1v74RcDFePAm2lI8zMvC5zwPVMCzeLD/Em7HqiJ7tc+1zwFWAjcCN4Xbk8A2YAuwrSqy4/085yAp8EKal6/Dw7UcuAwP3SWhXQzMAy4EXh9uR/Agtn8vJ+6fYnKvegIPTafHDgMH8N74QGjP4QEfq4rsSJ+/3K6lebkYWAPcDoziPf9vgC1Vkb1cZ23dUuAjkublPODtwHXAO4BrgTeHf67wuezzwIst7SDwMnCkpR0DTlRFdmqA5Q+FNC9HgPcBdwAfBLYCm4HfVUU29IvSfQt8GArdAFyKz4MOA3uBvVWRHfWzKfCDEnql1cD1nA74CLAH+COwC/gzsP//3x/pShgZ3QF8Ah8h3Q/8sCqyF2st7Bx6Dnyal28Dvgi8H/gT3lO8BMzH50JXA7uBLdXGWzcp8P2V5mWCz3knwr0aWIV/D54KbRewuyqyg3XVOdOlebkUD/7H8V7/nqrI9tRaVAc9BT7Ny+/jQf8a8GCn+Uyal7Pxec+d1cZbP5+ue+g+YFNVZE9M+8QRSfNyLj6XXoRvNy0B3gJcib+hLgH+BjwZ2lPAnqrI/ltLwZELQ/67gM/h06FvAY8My3C/18DnwHeqIjs2tbMllq576KPAZ/CLfjYBv2zqizOEcWKBa1HL7QJ8gWteSxsB5uKLXXNfo7VeH3ECn0uPc3rLaW9ozwB/H5YXk5wWRl63AF/Cp7kbgF/Vve5R26JdmpfXA5/GFz4exOc+uwZXzLmFraVLOb091NqW4kE/ga8qj3N6kWscv6jjlbZ2LHz+q1NoJxXimSPNy9XAl4FrgI3Az/u9nThVta/ShyulPgx8Eu/1f4ZPD/afz1LSvLwAuILOYV6G99D/AMbw/d/2dkChlG6keXkNsB6f4n4b2DzoBdPaA98qzctVwIeA2/Bh7e+Bx/DFwGeqIjs8ldOEedRC/AqtK0Jb2vLx5YDh+73Pcmaox6Z6LpFupXm5HB/qr8F7/M2D6vGHKvCt0ry8DH8nHMX3i1fic+H/4EPm9rnQhfhFInPx4fNBfE/5udDGWj5+oclXS8nMkOZlCnwVv6Lv6/hQ/+T5POfQBr6TsBAyH9/nbz/OUeCQgixNk+blVfhO17XAuqrIHj5f52pU4EVmsrCQfQ/wb+ALVZHt6/c5FHiRIRJGsR/Bh/i/ADZURfZKv46vwIsMobB79RV8Efvuqsi29uO4CrzIEAs7Vz8FtgPre/3pQf1OO5EhVhXZbuBd+M7TH9K8vKGX46mHF2mINC9vBn5UFdnK6R5DPbxIQ1RFtgN4Zy/HUA8vEhH18CIRUeBFIqLAi0REgReJiAIvEhEFXiQiCrxIRBR4kYgo8CIRUeBFIqLAi0REgReJiAIvEhEFXiQiCrxIRHoKfJIkn+rqP9T8s/Bd1zsEmlZz0+qF5tXcS7299vCNeqJoXr3QvJqbVi80r+baAi8iDaLAi0Sk18D/oC9VDE7T6oXm1dy0eqF5NU+73sH+EksRqZWG9CIRmdPNJydJcjNwIzBuZj9OkuROYAWwz8weOB8F9qpDzR8D3go8bGbb6q3uTO31hsfuBX5iZjtrLe4sOjzH7wFGgZ1mtqPe6s7Uod61wEUAZvbdWos7iyRJ3gvcbWZ3hftrgcXAb83s0akep9seftTMCuCScP9KM/smMO2/hDEAk2o2s/uBe4HltVZ1dpPqDW+q22ut6LW1vy5uA44Ap+or6Zza652Nh2e8vpLOzcy2A7taHlpoZhuAd3dznG4D3z7hb8ICwKQakySZB6zF/0DfMGp/Tlfh39Sbaqhlqtprnm9m3wM+UEcxU9Be7ywzW4+PVptiWtnratEuDIVGgUPAk8Ay/Enaa2a/nk4B51uHmj8L7AO2mtnjddbWSXu9ZvZEGM4dHfIhffvrIgVeMrP7aiytow713gIkwGEzG8oV+yRJrgO+AezEO6s1+KhkRzdDeq3Si0REq/QiEVHgRSKiwItERIEXiYgCLxIRBV4kIgq8SEQUeJGIKPAiEVHgRSKiwItE5H8sMpasmrK4VQAAAABJRU5ErkJggg=="></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0301040W0BBAAAA&amp;denomIds=3.1.4&amp;selectedTab=summary" target="_blank">Anoro Ellipta 55microg/dose / 22microg/dose dry pdr inh : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0&amp;denomIds=1.3.5&amp;selectedTab=summary">Lansoprazole</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2099</td>
      <td>Proton pump inhibitors</td>
      <td>9489</td>
      <td>0.22</td>
      <td>0.44</td>
      <td>0.16</td>
      <td>-1.37</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0AAAAAA&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Lansoprazole 30mg gastro-resistant capsules : 1117</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0AAABAB&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Lansoprazole 15mg gastro-resistant capsules : 885</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0AAAGAG&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Lansoprazole 15mg orodispersible tablets : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0AAAHAH&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Lansoprazole 30mg orodispersible tablets : 37</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0BBAEAH&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Zoton FasTab 30mg : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0103050L0BBADAG&amp;denomIds=1.3.5&amp;selectedTab=summary" target="_blank">Zoton FasTab 15mg : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=J82049&amp;numIds=0905013A0&amp;denomIds=9.5.1&amp;selectedTab=summary">Magnesium aspartate</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Magnesium</td>
      <td>25</td>
      <td>0.00</td>
      <td>0.54</td>
      <td>0.40</td>
      <td>-1.35</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>